Top

Osteoporosis International

Published in:

01-03-2021 | Vulgar Psoriasis | Original Article

Psoriasis is associated with an increased risk of osteoporosis: follow-up and nested case–control studies using a national sample cohort

Authors: J.W. Lee, C. Min, C.H. Bang, B.C. Kwon, H.G. Choi

Published in: Osteoporosis International | Issue 3/2021

Abstract

Summary

A total of 25,306 psoriasis participants were matched to 101,224 controls, and the occurrence of osteoporosis was analyzed. Additionally, 79,212 osteoporosis patients were matched to 79,212 controls and a previous history of psoriasis was analyzed. Psoriasis increased the risk of osteoporosis among participants aged ≥ 40 years.

Introduction

The aim of the present study was to evaluate the association between psoriasis and osteoporosis using two different studies.

Methods

Data from the Korean National Health Insurance Service-Health Screening Cohort of participants aged ≥ 40 years were collected from 2002 to 2013. Psoriasis and osteoporosis were included using International Classification of Diseases (ICD)-10 codes. In study I (a follow-up study), a total of 25,306 psoriasis participants were matched to 101,224 controls with respect to age, sex, income, and region of residence, and the occurrence of osteoporosis was analyzed. Crude (simple) and adjusted hazard ratios (HRs) were analyzed using a stratified Cox proportional hazard model. In study II (a nested case–control study), a total of 79,212 osteoporosis patients were matched to 79,212 controls and a previous history of psoriasis was analyzed. Crude and adjusted odds ratios (ORs) were analyzed using a conditional logistic regression analysis. Subgroup analyses were conducted according to age group and sex.

Results

The adjusted HR of osteoporosis was 1.09 (95% confidence interval [CI] = 1.05–1.13, P < 0.001) in study I. In the subgroup analysis according to age and sex, the results were consistent except for ≥ 60-year-old women. The adjusted OR of psoriasis was 1.21 (95% CI = 1.16–1.27, P < 0.001) in study II. All subgroups demonstrated high adjusted ORs of osteoporosis for psoriasis.

Conclusions

Psoriasis increased the risk of osteoporosis among participants aged ≥ 40 years in Korea.

Boehncke WH, Schön MP (2015) Psoriasis. Lancet 386:983–994CrossRef

Machado-Pinto J, Diniz Mdos S, Bavoso NC (2016) Psoriasis: new comorbidities. An Bras Dermatol 91:8–14CrossRef

Han JH, Lee JH, Han KD, Seo HM, Bang CH, Park YM, Lee JY, Park YG (2018) Epidemiology and medication trends in patients with psoriasis: a nationwide population-based cohort study from Korea. Acta Derm Venereol 98:396–400CrossRef

Alinaghi F, Calov M, Kristensen LE et al (2019) Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol 80(251):–265.e219

Duan X, Liu J, Mu Y, Liu T, Chen Y, Yu R, Xiong X, Wu T (2020) A systematic review and meta-analysis of the association between psoriasis and hypertension with adjustment for covariates. Medicine (Baltimore) 99:e19303CrossRef

Bang CH, Yoon JW, Chun JH, Han JH, Park YM, Lee SJ, Lee JH (2019) Association of Psoriasis With Mental Health Disorders in South Korea. JAMA Dermatol 155:747–749CrossRef

Muñoz-Torres M, Aguado P, Daudén E, Carrascosa JM, Rivera R (2019) Osteoporosis and psoriasis. Actas Dermosifiliogr 110:642–652CrossRef

Ogdie A, Harter L, Shin D, Baker J, Takeshita J, Choi HK, Love TJ, Gelfand JM (2017) The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study. Ann Rheum Dis 76:882–885CrossRef

Dreiher J, Weitzman D, Cohen AD (2009) Psoriasis and osteoporosis: a sex-specific association? J Invest Dermatol 129:1643–1649CrossRef

10.

Lajevardi V, Abedini R, Moghaddasi M, Nassiri SF, Goodarzi A (2017) Bone mineral density is lower in male than female patients with plaque-type psoriasis in Iran. Int J Womens Dermatol 3:201–205CrossRef

11.

Martinez-Lopez A, Blasco-Morente G, Giron-Prieto MS, Arrabal-Polo MA, Luque-Valenzuela M, Luna-Del Castillo JD, Tercedor-Sanchez J, Arias-Santiago S (2019) Linking of psoriasis with osteopenia and osteoporosis: a cross-sectional study. Indian J Dermatol Venereol Leprol 85:153–159CrossRef

12.

Park EJ, Joo IW, Jang MJ, Kim YT, Oh K, Oh HJ (2014) Prevalence of osteoporosis in the Korean population based on Korea National Health and Nutrition Examination Survey (KNHANES), 2008-2011. Yonsei Med J 55:1049–1057CrossRef

13.

Shah GM, Gong HS, Chae YJ, Kim YS, Kim J, Baek GH (2020) Evaluation and management of osteoporosis and sarcopenia in patients with distal radius fractures. Clin Orthop Surg 12:9–21CrossRef

14.

Kim SY, Min C, Oh DJ, Choi HG (2019) Tobacco smoking and alcohol consumption are related to benign parotid tumor: a nested case-control study using a national health screening cohort. Clin Exp Otorhinolaryngol 12:412–419CrossRef

15.

Kim SY, Kong IG, Lim H, Choi HG (2018) Increased risk of sudden sensory neural hearing loss in osteoporosis: a longitudinal follow-up study. J Clin Endocrinol Metab 103:3103–3109CrossRef

16.

Choi HG, Lee JK, Kong IG, Lim H, Kim SY (2019) Osteoporosis increases the risk of benign paroxysmal positional vertigo: a nested case-control study using a national sample cohort. Eur Arch Otorhinolaryngol 276:335–342CrossRef

17.

World Health Organization. Regional Office for the Western P (2000) The Asia-Pacific perspective : redefining obesity and its treatment. Sydney, Health Communications Australia

18.

Sung YK, Cho SK, Choi CB, Bae SC (2013) Prevalence and incidence of rheumatoid arthritis in South Korea. Rheumatol Int 33:1525–1532CrossRef

19.

Cho SK, Sung YK, Choi CB, Kwon JM, Lee EK, Bae SC (2013) Development of an algorithm for identifying rheumatoid arthritis in the Korean National Health Insurance claims database. Rheumatol Int 33:2985–2992CrossRef

20.

Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, Januel JM, Sundararajan V (2011) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173:676–682CrossRef

21.

Attia EA, Khafagy A, Abdel-Raheem S, Fathi S, Saad AA (2011) Assessment of osteoporosis in psoriasis with and without arthritis: correlation with disease severity. Int J Dermatol 50:30–35CrossRef

22.

Solak B, Dikicier BS, Celik HD, Erdem T (2016) Bone mineral density, 25-OH vitamin D and inflammation in patients with psoriasis. Photodermatol Photoimmunol Photomed 32:153–160CrossRef

23.

D'Epiro S, Marocco C, Salvi M, Mattozzi C, Luci C, Macaluso L, Giancristoforo S, Campoli M, Scarnò M, Migliaccio S, Calvieri S, Richetta A (2014) Psoriasis and bone mineral density: implications for long-term patients. J Dermatol 41:783–787CrossRef

24.

Pedreira PG, Pinheiro MM, Szejnfeld VL (2011) Bone mineral density and body composition in postmenopausal women with psoriasis and psoriatic arthritis. Arthritis Res Ther 13:R16CrossRef

25.

Millard TP, Antoniades L, Evans AV, Smith HR, Spector TD, Barker JN (2001) Bone mineral density of patients with chronic plaque psoriasis. Clin Exp Dermatol 26:446–448CrossRef

26.

Balato N, Balato A, Gallo L, Napolitano M, Patruno C, Ayala F (2012) Psoriasis and osteoporosis: data from a Southern Italian population. Arch Osteoporos 7:321–323CrossRef

27.

Kincse G, Bhattoa PH, Heredi E, Varga J, Szegedi A, Keri J, Gaal J (2015) Vitamin D3 levels and bone mineral density in patients with psoriasis and/or psoriatic arthritis. J Dermatol 42:679–684CrossRef

28.

Osmancevic A, Landin-Wilhelmsen K, Larko O, Mellstrom D, Wennberg AM, Hulthen L, Krogstad AL (2008) Risk factors for osteoporosis and bone status in postmenopausal women with psoriasis treated with UVB therapy. Acta Derm Venereol 88:240–246PubMed

29.

Shah K, Mellars L, Changolkar A, Feldman SR (2017) Real-world burden of comorbidities in US patients with psoriasis. J Am Acad Dermatol 77:287–292.e284CrossRef

30.

Kathuria P, Gordon KB, Silverberg JI (2017) Association of psoriasis and psoriatic arthritis with osteoporosis and pathological fractures. J Am Acad Dermatol 76:1045–1053.e1043CrossRef

31.

Modalsli EH, Asvold BO, Romundstad PR, Langhammer A, Hoff M, Forsmo S, Naldi L, Saunes M (2017) Psoriasis, fracture risk and bone mineral density: the HUNT Study, Norway. Br J Dermatol 176:1162–1169CrossRef

32.

Keller JJ, Kang JH, Lin HC (2013) Association between osteoporosis and psoriasis: results from the Longitudinal Health Insurance Database in Taiwan. Osteoporos Int 24:1835–1841CrossRef

33.

Puth MT, Klaschik M, Schmid M, Weckbecker K, Münster E (2018) Prevalence and comorbidity of osteoporosis- a cross-sectional analysis on 10,660 adults aged 50 years and older in Germany. BMC Musculoskelet Disord 19:144CrossRef

34.

Honma M, Shibuya T, Iinuma S, Kishibe M, Takahashi H, Ishida-Yamamoto A (2017) Close correlation of bone mineral density and body mass index in Japanese psoriasis patients. J Dermatol 44:e1–e2CrossRef

35.

Kocijan R, Englbrecht M, Haschka J, Simon D, Kleyer A, Finzel S, Kraus S, Resch H, Muschitz C, Engelke K, Sticherling M, Rech J, Schett G (2015) Quantitative and qualitative changes of bone in psoriasis and psoriatic arthritis patients. J Bone Miner Res 30:1775–1783CrossRef

36.

Kastelan D, Kastelan M, Massari LP, Korsic M (2006) Possible association of psoriasis and reduced bone mineral density due to increased TNF-alpha and IL-6 concentrations. Med Hypotheses 67:1403–1405CrossRef

37.

Grisar J, Bernecker PM, Aringer M, Redlich K, Sedlak M, Wolozcszuk W, Spitzauer S, Grampp S, Kainberger F, Ebner W, Smolen JS, Pietschmann P (2002) Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation. J Rheumatol 29:1430–1436PubMed

38.

Lee YH, Song GG (2018) Association between circulating 25-hydroxyvitamin D levels and psoriasis, and correlation with disease severity: a meta-analysis. Clin Exp Dermatol 43:529–535CrossRef

39.

Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. Jama 323:1945–1960CrossRef

40.

Eun SJ, Jang S, Lee JY, Do YK, Jo SJ (2017) High rate of systemic corticosteroid prescription among outpatient visits for psoriasis: a population-based epidemiological study using the Korean National Health Insurance database. J Dermatol 44:1027–1032CrossRef

41.

Chandran S, Aldei A, Johnson SR, Cheung AM, Salonen D, Gladman DD (2016) Prevalence and risk factors of low bone mineral density in psoriatic arthritis: a systematic review. Semin Arthritis Rheum 46:174–182CrossRef

Title: Psoriasis is associated with an increased risk of osteoporosis: follow-up and nested case–control studies using a national sample cohort
Authors: J.W. Lee
C. Min
C.H. Bang
B.C. Kwon
H.G. Choi
Publication date: 01-03-2021
Publisher: Springer London
Keywords: Vulgar Psoriasis
Osteoporosis
Osteoporosis
Published in: Osteoporosis International / Issue 3/2021
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-020-05724-2

At a glance: The STEP trials

Springer Medicine

Psoriasis is associated with an increased risk of osteoporosis: follow-up and nested case–control studies using a national sample cohort

Abstract

Summary

Introduction

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2021

Therapeutic efficacy of zoledronic acid combined with calcitriol in elderly patients receiving total hip arthroplasty or hemiarthroplasty for osteoporotic femoral neck fracture

Defining an international cut-off of two-legged countermovement jump power for sarcopenia and dysmobility syndrome

Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy

Sleep duration and bone health measures in older men

Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patients

Differential effects of abaloparatide and teriparatide on hip cortical volumetric BMD by DXA-based 3D modeling